The Research Foundation for Microbial Diseases of Osaka University (hereinafter,”Biken”) announced that it joined the Japanese Pharmaceutical Manufacturers Association (hereinafter,”JPMA ; ”http://www.jpma.or.jp/english/) .

Koich Yamanishi, Director General of Biken, said : “Recognizing expectations of society for stable supply of vaccines as well as research and development for more excellent vaccines, we will make our best efforts to fulfill our responsibilities. Having joined the JPMA, while working collaboratively with other member companies, we aspire to contribute to the entire Pharmaceutical Industry and the health of not only the people in Japan but also the people throughout the world.”

Biken

Biken has a long history stretching back to its establishment in 1934. Since then, it has been engaged in the development, production, and supply of a wide variety of important vaccines based on the results of pioneering basic research activities conducted by the Research Institute for Microbial Diseases, Osaka University for more than 80 years. Through these efforts, Biken has contributed to the prevention of infections both in Japan and overseas. The principal Biken vaccines include the varicella vaccine and influenza vaccine. Biken continues to place a premium on public welfare and to the further development of its work. Biken is committed to ensuring the continuous and stable supply of high-quality vaccines through the dedicated efforts of its personnel. Moreover, Biken will promote its work in order to improve global health and quality of life (QOL) through the development and supply of innovative next-generation vaccines.

Contact:
Miho Maruoka, Public Relations Section
E-mail: mmaruoka@mail.biken.or.jp